Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trialNicole Basset‐Séguin, Johan Hansson, Axel Hauschild et al.|European Journal of Cancer|2017Cited by 284
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trialNicole Basset‐Séguin, Johan Hansson, Axel Hauschild et al.|The Lancet Oncology|2015Cited by 244
Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysisL. Legendre, C. Paul, Thomas Barnetche et al.|Journal of the American Academy of Dermatology|2015Cited by 204
Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600–Mutant Unresectable or Metastatic MelanomaReinhard Dummer, Dirk Schadendorf, Paul Lorigan et al.|Zurich Open Repository and Archive (University of Zurich)|2022Cited by 146
Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical TrialAnne Montfort, Nicolás Meyer|Clinical Cancer Research|2020Cited by 101